|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.76 EUR | -1.47% |
|
-5.34% | +15.34% |
| 05/03 | Origo Quest Falls 6.3 Percent in February – Increases Holdings in Chemometec and Dynavox | FW |
| 05/03 | Origo Seleqt Down 1.1 Percent in February - Increased Stake in Raysearch | FW |
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Profitability | |||||
Return on Assets | - | 5.34 | 8.19 | 7 | 8.02 |
Return on Total Capital | - | 9.75 | 14.65 | 12.09 | 13.93 |
Return On Equity % | - | 11.37 | 23.19 | 17.56 | 24.09 |
Return on Common Equity | - | 11.37 | 23.19 | 17.56 | 24.09 |
Margin Analysis | |||||
Gross Profit Margin % | 21.37 | 19.84 | 24.85 | 26.3 | 26.17 |
SG&A Margin | 12.56 | 10.11 | 10.51 | 11.51 | 10.65 |
EBITDA Margin % | 8.09 | 9.92 | 13.92 | 13.93 | 14.74 |
EBITA Margin % | 5.78 | 8.11 | 12.08 | 11.83 | 12.7 |
EBIT Margin % | 5.72 | 8.05 | 11.99 | 11.53 | 12.7 |
Income From Continuing Operations Margin % | 17.29 | 4.77 | 9.46 | 7.43 | 9.38 |
Net Income Margin % | 17.29 | 4.77 | 9.46 | 7.43 | 9.38 |
Net Avail. For Common Margin % | 17.29 | 4.77 | 9.46 | 7.43 | 9.38 |
Normalized Net Income Margin | 3.76 | 5.21 | 7.81 | 7.31 | 7.49 |
Levered Free Cash Flow Margin | - | 2.82 | 4.36 | 23.53 | 6.34 |
Unlevered Free Cash Flow Margin | - | 3.02 | 4.59 | 24.04 | 6.8 |
Asset Turnover | |||||
Asset Turnover | - | 1.06 | 1.09 | 0.97 | 1.01 |
Fixed Assets Turnover | - | 7.67 | 7.73 | 6.39 | 6.41 |
Receivables Turnover (Average Receivables) | - | 6.2 | 6.94 | 6.3 | 6.25 |
Inventory Turnover (Average Inventory) | - | 3.48 | 3.2 | 2.82 | 2.86 |
Short Term Liquidity | |||||
Current Ratio | 1.43 | 1.45 | 1.52 | 1.7 | 1.72 |
Quick Ratio | 0.86 | 0.84 | 0.89 | 0.94 | 0.96 |
Operating Cash Flow to Current Liabilities | 0.09 | 0.19 | 0.28 | 0.28 | 0.32 |
Days Sales Outstanding (Average Receivables) | - | 58.87 | 52.57 | 58.12 | 58.36 |
Days Outstanding Inventory (Average Inventory) | - | 104.76 | 114.19 | 129.63 | 127.45 |
Average Days Payable Outstanding | - | 55.34 | 54.22 | 49.32 | 48.06 |
Cash Conversion Cycle (Average Days) | - | 108.29 | 112.55 | 138.42 | 137.76 |
Long Term Solvency | |||||
Total Debt/Equity | 26.39 | 20.05 | 31.12 | 53.42 | 39.91 |
Total Debt / Total Capital | 20.88 | 16.7 | 23.73 | 34.82 | 28.53 |
LT Debt/Equity | 9.82 | 6.8 | 13.93 | 49.47 | 36.54 |
Long-Term Debt / Total Capital | 7.77 | 5.66 | 10.63 | 32.24 | 26.12 |
Total Liabilities / Total Assets | 55.9 | 55.21 | 55.68 | 62.37 | 58.95 |
EBIT / Interest Expense | 14.42 | 25.23 | 32.77 | 14.27 | 17.41 |
EBITDA / Interest Expense | 22.6 | 33.39 | 40.19 | 18.53 | 21.7 |
(EBITDA - Capex) / Interest Expense | 17.8 | 25.82 | 32.69 | 15.61 | 16.48 |
Total Debt / EBITDA | 1.51 | 0.83 | 0.84 | 1.32 | 1.04 |
Net Debt / EBITDA | 0.75 | 0.34 | 0.57 | 0.31 | 0.03 |
Total Debt / (EBITDA - Capex) | 1.92 | 1.07 | 1.04 | 1.57 | 1.37 |
Net Debt / (EBITDA - Capex) | 0.96 | 0.44 | 0.7 | 0.37 | 0.04 |
Growth Over Prior Year | |||||
Total Revenues, 1 Yr. Growth % | - | 28.48 | 5.5 | -16.06 | 1.21 |
Gross Profit, 1 Yr. Growth % | - | 19.24 | 32.15 | -11.15 | 0.71 |
EBITDA, 1 Yr. Growth % | - | 57.65 | 47.98 | -15.98 | 7.23 |
EBITA, 1 Yr. Growth % | - | 80.32 | 57.11 | -17.77 | 8.86 |
EBIT, 1 Yr. Growth % | - | 80.81 | 57.16 | -19.28 | 11.44 |
Earnings From Cont. Operations, 1 Yr. Growth % | - | -64.59 | 109.29 | -34 | 27.68 |
Net Income, 1 Yr. Growth % | - | -64.59 | 109.29 | -34 | 27.68 |
Normalized Net Income, 1 Yr. Growth % | - | 78.02 | 58.09 | -21.48 | 3.78 |
Diluted EPS Before Extra, 1 Yr. Growth % | - | - | - | -33.89 | 27.64 |
Accounts Receivable, 1 Yr. Growth % | - | 0.03 | -11.61 | -2.74 | 6.72 |
Inventory, 1 Yr. Growth % | - | 28.59 | -8.35 | -5.12 | 5.33 |
Net Property, Plant and Equip., 1 Yr. Growth % | - | 3.13 | 6.06 | -2.82 | 4.86 |
Total Assets, 1 Yr. Growth % | - | 8.23 | -3.07 | -8.14 | 3.1 |
Tangible Book Value, 1 Yr. Growth % | - | 15.77 | -5.11 | -31.49 | 23.23 |
Common Equity, 1 Yr. Growth % | - | 9.92 | -4.08 | -22 | 12.47 |
Cash From Operations, 1 Yr. Growth % | - | 122.53 | 36.6 | -20.38 | 18.79 |
Capital Expenditures, 1 Yr. Growth % | - | 62.85 | 19.83 | -27.94 | 63.7 |
Levered Free Cash Flow, 1 Yr. Growth % | - | - | 63.1 | 353.24 | -72.72 |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | 60.32 | 339.88 | -71.38 |
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | 10 |
Compound Annual Growth Rate Over Two Years | |||||
Total Revenues, 2 Yr. CAGR % | - | - | 16.42 | -5.89 | -7.82 |
Gross Profit, 2 Yr. CAGR % | - | - | 25.53 | 8.36 | -5.41 |
EBITDA, 2 Yr. CAGR % | - | - | 52.73 | 11.5 | -5.16 |
EBITA, 2 Yr. CAGR % | - | - | 68.31 | 13.66 | -5.48 |
EBIT, 2 Yr. CAGR % | - | - | 68.57 | 12.63 | -5.16 |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | - | -13.91 | 17.52 | -8.21 |
Net Income, 2 Yr. CAGR % | - | - | -13.91 | 17.52 | -8.21 |
Normalized Net Income, 2 Yr. CAGR % | - | - | 67.76 | 11.42 | -9.73 |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | - | - | -8.14 |
Accounts Receivable, 2 Yr. CAGR % | - | - | -5.97 | -7.29 | 1.88 |
Inventory, 2 Yr. CAGR % | - | - | 8.56 | -6.75 | -0.03 |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | - | 4.58 | 1.52 | 0.95 |
Total Assets, 2 Yr. CAGR % | - | - | 2.43 | -5.64 | -2.68 |
Tangible Book Value, 2 Yr. CAGR % | - | - | 4.81 | -19.38 | -8.76 |
Common Equity, 2 Yr. CAGR % | - | - | 2.68 | -13.5 | -6.34 |
Cash From Operations, 2 Yr. CAGR % | - | - | 74.35 | 4.29 | -2.75 |
Capital Expenditures, 2 Yr. CAGR % | - | - | 39.69 | -7.07 | 8.61 |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | - | 171.89 | 11.19 |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | - | 165.56 | 12.21 |
Compound Annual Growth Rate Over Three Years | |||||
Total Revenues, 3 Yr. CAGR % | - | - | - | 4.4 | -3.58 |
Gross Profit, 3 Yr. CAGR % | - | - | - | 11.87 | 5.74 |
EBITDA, 3 Yr. CAGR % | - | - | - | 25.15 | 10 |
EBITA, 3 Yr. CAGR % | - | - | - | 32.56 | 11.96 |
EBIT, 3 Yr. CAGR % | - | - | - | 31.88 | 12.23 |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | - | -21.21 | 20.82 |
Net Income, 3 Yr. CAGR % | - | - | - | -21.21 | 20.82 |
Normalized Net Income, 3 Yr. CAGR % | - | - | - | 30.25 | 8.81 |
Accounts Receivable, 3 Yr. CAGR % | - | - | - | -4.91 | -2.83 |
Inventory, 3 Yr. CAGR % | - | - | - | 3.79 | -2.89 |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | - | 2.06 | 2.63 |
Total Assets, 3 Yr. CAGR % | - | - | - | -1.22 | -2.81 |
Tangible Book Value, 3 Yr. CAGR % | - | - | - | -9.04 | -7.56 |
Common Equity, 3 Yr. CAGR % | - | - | - | -6.31 | -5.59 |
Cash From Operations, 3 Yr. CAGR % | - | - | - | 34.26 | 8.91 |
Capital Expenditures, 3 Yr. CAGR % | - | - | - | 12.04 | 12.23 |
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | - | - | 26.34 |
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | - | - | 26.38 |
- Stock Market
- Equities
- KALMAR Stock
- Financials Kalmar Oyj
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















